Sanofi delivers strong 2019 business EPS growth of 6.8% at CER
Fourth quarter and full year 2019 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.
!-- notag -->!-- notag -->!-- notag -->
Fourth quarter and full year 2019 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.